|
RNA Atrium Therapeutics Inc 2093101 |
| Balance Sheet |
|
Current Assets
|
$285,565,000.00 |
|
Assets
|
$292,360,000.00 |
|
Current Liabilities
|
$21,905,000.00 |
|
Liabilities
|
$58,256,000.00 |
|
Equity
|
$234,104,000.00 |
|
Shares Out
|
17105643.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-31,143,000.00 |
|
Investing Cash Flow
|
$-2,098,000.00 |
| Market Analysis |
Market Cap
|
$196,030,668.78 |
|
Price
|
$11.40 |
|
BVPS
|
13.69 |
|
PB
|
0.84 |
|
EPS
|
-0.97 |
|
PS
|
2.97 |
|
FCF
|
$-33,241,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-4.97 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.21 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-1.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNA documents filed with the SEC.
RNA Filings
Clear
